MediGene says partnering negotiations for pancreatic cancer drug are at 'advanced stage'

The new chief executive officer of MediGene AG has said that partnering negotiations for the pancreatic cancer drug, EndoTAG-1, have reached an 'advanced stage' and management is weighing up its options.